2024 Vol.42, N°9 - Table of contents
September 2024
One year in review
CER18131
2024,42,9
Pg. 1707-1713
Free to view
Pathogenesis of rheumatoid arthritis: one year in review 2024
A. D'orazio, A.L. Cirillo, G. Greco, E. Di Ruscio, M. Latorre, F. Pisani, A. Alunno, I. Puxeddu
DOI: https://doi.org/10.55563/clinexprheumatol/0307ed
A. D'orazio, A.L. Cirillo, G. Greco, E. Di Ruscio, M. Latorre, F. Pisani, A. Alunno, I. Puxeddu
DOI: https://doi.org/10.55563/clinexprheumatol/0307ed
Environmental Rheumatology
CER17630
2024,42,9
Pg. 1714-1719
Free to view
The great challenge: bone fragility and environment
M. Mazzantini, G. De Mattia
DOI: https://doi.org/10.55563/clinexprheumatol/7azn44
M. Mazzantini, G. De Mattia
DOI: https://doi.org/10.55563/clinexprheumatol/7azn44
CER17374
2024,42,9
Pg. 1720-1728
Free to view
Exploring the link between dietary omega-3 and omega-6 fatty acid intake and rheumatoid arthritis risk: NHANES 1999-2020 study
T. Kang, Y. Xi, T. Qian, S. Lu, M. Du, X. Shi, X. Hou
DOI: https://doi.org/10.55563/clinexprheumatol/91tmfb
T. Kang, Y. Xi, T. Qian, S. Lu, M. Du, X. Shi, X. Hou
DOI: https://doi.org/10.55563/clinexprheumatol/91tmfb
Full Papers
CER16976
2024,42,9
Pg. 1729-1735
Free to view
Polyacrylamide gel versus hyaluronic acid for the treatment of knee osteoarthritis: a randomised controlled study
H. Bliddal, J. Beier, A. Hartkopp, P.G. Conaghan, M. Henriksen
DOI: https://doi.org/10.55563/clinexprheumatol/i3fqee
H. Bliddal, J. Beier, A. Hartkopp, P.G. Conaghan, M. Henriksen
DOI: https://doi.org/10.55563/clinexprheumatol/i3fqee
CER17358
2024,42,9
Pg. 1736-1743
Free to view
Effectiveness of tofacitinib monotherapy for patients with IgG4-RD or idiopathic retroperitoneal fibrosis
X. Cao, S. Li, J. Wan, Z. Yu, G. Dong, W. Zhou
DOI: https://doi.org/10.55563/clinexprheumatol/61mt03
X. Cao, S. Li, J. Wan, Z. Yu, G. Dong, W. Zhou
DOI: https://doi.org/10.55563/clinexprheumatol/61mt03
CER17464
2024,42,9
Pg. 1744-1749
Free to view
Treat-to-target and shared decision-making in systemic lupus erythematosus from the patients’ perspective: results from an international patient survey
J. Mucke, D.T. Pencheva, A.R. Parra Sánchez, K. Cramer, M. Schneider, I.E. Bultink
DOI: https://doi.org/10.55563/clinexprheumatol/jp828o
J. Mucke, D.T. Pencheva, A.R. Parra Sánchez, K. Cramer, M. Schneider, I.E. Bultink
DOI: https://doi.org/10.55563/clinexprheumatol/jp828o
CER17169
2024,42,9
Pg. 1750-1755
Free to view
Endothelial mesenchymal transition promotes pannus formation in ankylosing spondylitis by activation of TGF-β/SMAD signalling pathway
S. Li, Z. Hou, Y. Gong, J. Peng, H. Liang, D. Wang, L. Lin
DOI: https://doi.org/10.55563/clinexprheumatol/9u1vzp
S. Li, Z. Hou, Y. Gong, J. Peng, H. Liang, D. Wang, L. Lin
DOI: https://doi.org/10.55563/clinexprheumatol/9u1vzp
CER17429
2024,42,9
Pg. 1756-1762
Free to view
Lower total cholesterol and triglyceride levels in ankylosing spondylitis than non-inflammatory rheumatic disease controls in a 1978-98 study: a potential effect of increased physical energetics in manual occupations in the pre-2000 chronologic era
A.T. Masi, P.C. Mohan, T. Murugan, C.R. Evans, M.J. Ryan, M.L. Brezka, V. Hanna, G.R. Cooper, J.C. Aldag
DOI: https://doi.org/10.55563/clinexprheumatol/u41mn1
A.T. Masi, P.C. Mohan, T. Murugan, C.R. Evans, M.J. Ryan, M.L. Brezka, V. Hanna, G.R. Cooper, J.C. Aldag
DOI: https://doi.org/10.55563/clinexprheumatol/u41mn1
CER17274
2024,42,9
Pg. 1763-1772
Free to view
Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL dataset
S. Ciciriello, G.O. Littlejohn, T. Treuer, K.A. Gibson, E. Haladyj, P. Youssef, P. Bird, C. O'sullivan, T. Smith, C.T. Deakin
DOI: https://doi.org/10.55563/clinexprheumatol/n0kjax
S. Ciciriello, G.O. Littlejohn, T. Treuer, K.A. Gibson, E. Haladyj, P. Youssef, P. Bird, C. O'sullivan, T. Smith, C.T. Deakin
DOI: https://doi.org/10.55563/clinexprheumatol/n0kjax
CER17267
2024,42,9
Pg. 1773-1780
Free to view
Red blood cell distribution width as a surrogate biomarker of damage and disease activity in patients with systemic lupus erythematosus
J. Mercader-Salvans, M. García-González, J.C. Quevedo-Abeledo, A. Quevedo-Rodríguez, F. Gómez-Bernal, M. Hernández-Díaz, M. Pestana-Eliche, M. Markthaler, C. Martín-González, C. Gómez-Moreno, M.Á. González-Gay, I. Ferraz-Amaro
DOI: https://doi.org/10.55563/clinexprheumatol/f0jnnm
J. Mercader-Salvans, M. García-González, J.C. Quevedo-Abeledo, A. Quevedo-Rodríguez, F. Gómez-Bernal, M. Hernández-Díaz, M. Pestana-Eliche, M. Markthaler, C. Martín-González, C. Gómez-Moreno, M.Á. González-Gay, I. Ferraz-Amaro
DOI: https://doi.org/10.55563/clinexprheumatol/f0jnnm
CER17390
2024,42,9
Pg. 1781-1791
Free to view
Uncovering risk factors for adverse events and infections in rheumatoid arthritis and rheumatoid arthritis with interstitial lung disease under treatment with biologics or targeted synthetic DMARDs: insights from the KOBIO Registry
J.-W. Kim, K. Shin, J. Jung, C.-H. Suh, J. Kim, S.-K. Lee, H.-A. Kim
DOI: https://doi.org/10.55563/clinexprheumatol/6h1euo
J.-W. Kim, K. Shin, J. Jung, C.-H. Suh, J. Kim, S.-K. Lee, H.-A. Kim
DOI: https://doi.org/10.55563/clinexprheumatol/6h1euo
CER17443
2024,42,9
Pg. 1792-1801
Neutrophils impaired by anti-galectin-3 antibodies elicit inflammation of endothelial cells to aggregate the development of lupus cutaneous vasculitis
F.-Q. Hu, S.-Y. Lu, Z.-R. Shi, Y.-X. Lai, Y.-L. Ren, J. Wu, G.-Z. Tan, K. Zeng, L. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/xj2knk
F.-Q. Hu, S.-Y. Lu, Z.-R. Shi, Y.-X. Lai, Y.-L. Ren, J. Wu, G.-Z. Tan, K. Zeng, L. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/xj2knk
CER17389
2024,42,9
Pg. 1802-1811
Performance of a novel high-resolution infrared thermography marker in detecting and assessing joint inflammation: a comparison with joint ultrasound
K. Triantafyllias, M. Clasen, M. De Blasi, M. Berres, E. Nikolodimos, A. Schwarting
DOI: https://doi.org/10.55563/clinexprheumatol/ne4k8y
K. Triantafyllias, M. Clasen, M. De Blasi, M. Berres, E. Nikolodimos, A. Schwarting
DOI: https://doi.org/10.55563/clinexprheumatol/ne4k8y
CER17371
2024,42,9
Pg. 1812-1819
Association between Mycobacterium tuberculosis infection and the risk of inflammatory arthritides
M. Han, J.W. Ha, I. Jung, C.Y. Kim, S.S. Ahn
DOI: https://doi.org/10.55563/clinexprheumatol/cccp8o
M. Han, J.W. Ha, I. Jung, C.Y. Kim, S.S. Ahn
DOI: https://doi.org/10.55563/clinexprheumatol/cccp8o
CER17354
2024,42,9
Pg. 1820-1829
Free to view
Impact of anti-rheumatic treatment on the individual components of the ACR composite score in patients with rheumatoid arthritis: real-world data
M. Movahedi, D. Choquette, L. Coupal, E. Keystone, C. Bombardier, L. Bessette
DOI: https://doi.org/10.55563/clinexprheumatol/6qobnr
M. Movahedi, D. Choquette, L. Coupal, E. Keystone, C. Bombardier, L. Bessette
DOI: https://doi.org/10.55563/clinexprheumatol/6qobnr
CER17552
2024,42,9
Pg. 1830-1837
Risk of rituximab-induced hepatitis B flare after antiviral discontinuation in rheumatic patients with chronic hepatitis B virus
T.-Y. Lan, T.-W. Chang, T.-C. Tseng, T.-J. Lee, J.-H. Kao, C.-F. Cheng, S.-C. Huang, C.-Y. Shen, C.-H. Lu, H.-C. Yang, K.-J. Li, S.-C. Hsieh
DOI: https://doi.org/10.55563/clinexprheumatol/qh1gj3
T.-Y. Lan, T.-W. Chang, T.-C. Tseng, T.-J. Lee, J.-H. Kao, C.-F. Cheng, S.-C. Huang, C.-Y. Shen, C.-H. Lu, H.-C. Yang, K.-J. Li, S.-C. Hsieh
DOI: https://doi.org/10.55563/clinexprheumatol/qh1gj3
Brief Papers
CER17424
2024,42,9
Pg. 1838-1841
The change over time in the prescription pattern of the first targeted drug after failure of conventional therapy in patients with rheumatoid arthritis: a 20-year real-world experience
G. Maioli, G. Cincinelli, M. Biggioggero, R. Caporali, E.G. Favalli
DOI: https://doi.org/10.55563/clinexprheumatol/c4pgcd
G. Maioli, G. Cincinelli, M. Biggioggero, R. Caporali, E.G. Favalli
DOI: https://doi.org/10.55563/clinexprheumatol/c4pgcd
CER17579
2024,42,9
Pg. 1842-1845
Free to view
Beyond diagnosis: exploring the significance of IgG4+ plasma cell count through immunostaining in IgG4-related disease
E. Martín-Nares, J. Guerrero-Castillo, A. Ángeles-Ángeles, J. Delgado-De la mora, D. Montante-Montes de oca, G. Hernández-Molina
DOI: https://doi.org/10.55563/clinexprheumatol/cniut0
E. Martín-Nares, J. Guerrero-Castillo, A. Ángeles-Ángeles, J. Delgado-De la mora, D. Montante-Montes de oca, G. Hernández-Molina
DOI: https://doi.org/10.55563/clinexprheumatol/cniut0
Reviews
CER17083
2024,42,9
Pg. 1846-1855
Free to view
Insights into the cellular basis of skin inflammation in systemic autoimmune rheumatic diseases from single-cell technologies
K.Y. Su, C. Roberts, A.H. Heagerty, J.A. Reynolds
DOI: https://doi.org/10.55563/clinexprheumatol/8vvgva
K.Y. Su, C. Roberts, A.H. Heagerty, J.A. Reynolds
DOI: https://doi.org/10.55563/clinexprheumatol/8vvgva
CER17475
2024,42,9
Pg. 1856-1866
Free to view
Risk factors for psoriatic arthritis development in psoriasis patients: myths, pitfalls, and pearls
Y.S. Patt, A. Watad, I. Giovannini, W.H. Abu-Obeida, E. Errichetti, P. David, G. De Marco, D. Mcgonagle, A. Zabotti
DOI: https://doi.org/10.55563/clinexprheumatol/h6176m
Y.S. Patt, A. Watad, I. Giovannini, W.H. Abu-Obeida, E. Errichetti, P. David, G. De Marco, D. Mcgonagle, A. Zabotti
DOI: https://doi.org/10.55563/clinexprheumatol/h6176m
Paediatric Rheumatology
CER17075
2024,42,9
Pg. 1867-1875
Free to view
Uveitis as predictor of disease flare after the first anti-TNF withdrawal in oligoarticular and polyarticular juvenile idiopathic arthritis: a multicentric Italian experience
I. Maccora, V. Accardo, M. Cattalini, I. Pagnini, A. Taddio, E. Marrani, F. La Torre, M.V. Mastrolia, I. Bellicini, S. Pastore, G. Simonini
DOI: https://doi.org/10.55563/clinexprheumatol/3mxsll
I. Maccora, V. Accardo, M. Cattalini, I. Pagnini, A. Taddio, E. Marrani, F. La Torre, M.V. Mastrolia, I. Bellicini, S. Pastore, G. Simonini
DOI: https://doi.org/10.55563/clinexprheumatol/3mxsll
CER17319
2024,42,9
Pg. 1876-1883
Free to view
Ultrasound-detected tenosynovitis in ankles with clinical arthritis and short-term outcome of patients with new-onset juvenile idiopathic arthritis
S. Lanni, O. De Lucia, D. Consonni, F. Chironi, S. Costi, S.M. Orsi, G. Beretta, M. Rossano, R. Caporali, C. Agostoni, G. Filocamo
on behalf of the Paediatric Rheumatology Associated Group of the Milan Area (PRAGMA)
DOI: https://doi.org/10.55563/clinexprheumatol/r35akp
S. Lanni, O. De Lucia, D. Consonni, F. Chironi, S. Costi, S.M. Orsi, G. Beretta, M. Rossano, R. Caporali, C. Agostoni, G. Filocamo
on behalf of the Paediatric Rheumatology Associated Group of the Milan Area (PRAGMA)
DOI: https://doi.org/10.55563/clinexprheumatol/r35akp
Letters to the Editor
CER17350
2024,42,9
Pg. 1884-1885
Free to view
Plasma amino acid concentration in patients with IgG4-related disease
H. Nakamura, M. Kanda, H. Amaike, K. Nagahata, H. Takahashi
DOI: https://doi.org/10.55563/clinexprheumatol/std9t8
H. Nakamura, M. Kanda, H. Amaike, K. Nagahata, H. Takahashi
DOI: https://doi.org/10.55563/clinexprheumatol/std9t8
CER17165
2024,42,9
Pg. 1886
Free to view
A rare IgG4-related acute sclerosing pachymeningitis leading to spinal cord compression: diagnosis and treatment
X. Gong, Y. Liu, Y. Su, S. Liu, H. An, L. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/hdtkjz
X. Gong, Y. Liu, Y. Su, S. Liu, H. An, L. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/hdtkjz
CER17493
2024,42,9
Pg. 1887-1888
Free to view
Clinical response to brodalumab in a patient affected by refractory SAPHO syndrome
E. D'ignazio, E. Trovato, L. Cantarini, L. Calabrese, B. Frediani, S. Gentileschi
DOI: https://doi.org/10.55563/clinexprheumatol/qhq2o0
E. D'ignazio, E. Trovato, L. Cantarini, L. Calabrese, B. Frediani, S. Gentileschi
DOI: https://doi.org/10.55563/clinexprheumatol/qhq2o0
Meeting Abstracts
CER18127
2024,42,9
Pg. 1889-1997
Free to view
Fourteenth International Congress on Spondyloarthritides
M.A. D'agostino, N. Haroon, D. Elewaut, F. Van Den Bosch
Ghent, Belgium, 5-7 September 2024
DOI: https://doi.org/10.55563/clinexprheumatol/7l5roe
M.A. D'agostino, N. Haroon, D. Elewaut, F. Van Den Bosch
Ghent, Belgium, 5-7 September 2024
DOI: https://doi.org/10.55563/clinexprheumatol/7l5roe